Emerging Therapeutics and Biosimilars: Advancing the Future of Osteoporosis Care

Sequential Therapy and Switching Strategies in Osteoporosis: Insights for Improved Outcomes

How much can staying active in adulthood realy cut dementia risk?

Advanced Imaging in Osteoporosis: Integrating Trabecular Bone Score for Enhanced Fracture Risk Assessment

How are major medical societies responding to FDA changes to menopause therapy labels?

Could over-the-counter painkillers truly outperform opioids after dental surgery?

Managing CNS Involvement in HER2+ Lung Cancer

Could a chemo-free regimen surpass the standard triplet in HER2+ Breast Cancer?

Evolving Second-Line Strategies in HER2+ Lung Cancer

First-Line Strategies in HER2+ Lung Cancer

Can HER2+ Metastatic Breast Cancer Be Cured?

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

Could there be a long-awaited breakthrough in first-line therapy for triple-negative breast cancer?

Early-Stage HER2+ Breast Cancer

Could the choice of diabetes medication change a patient’s cardiovascular risk?

Do updated COVID vaccines protect U.S. veterans from severe outcomes?

When can stage II–III colon cancer be considered cured after treatment?

ICML 2025: Novel Agents in CLL

Could SGLT2 inhibitors help lower the risk of sudden cardiac death?

ICML 2025: Regimens for Patients With High-Risk CLL